The i-port Advance is a small, circular, low profile device, about the size of a quarter, that stays on the skin like a bandage. Each i-port Advance can be used for three days, during which time the person with diabetes injects their insulin into the port instead of directly into the skin. With only one skin puncture every three days (when applying a new device) instead of multiple punctures each day, i-port Advance reduces bruising, pain and scar tissue while promoting healing. Each i-port Advance comes with a disposable serter (insertion aid) that provides nearly pain-free application of i-port to the skin. Because the device may remain in place for up to 72 hours, i-port Advance accommodates multiple drug injections without the discomfort of additional needle sticks
The i-port Advance may be used on a wide range of patients, including adults and children and is indicated for use with both insulin pens and syringes.
Healthcare professionals and people with diabetes interested in learning more about the product should contact Medtronic’s customer center at 800.646.4633 or online at www.i-port.com.
Hi would like to know if i-port is available in Australia
I am very interested to learn more about this little Pod type device. Is it available in Australia ? What kind of price tag ? Is it NDSS covered ? Can Long acting and fast acting insulin be injected at the same time ? Does the insulin enter the skin immediately or slowly ? Would it be suitable for an infant ?
Iport is not a new device, though this Inset/Mio model is an update…
Its also not a medtronic device.. It was designed and developed by Patton Medical.. Not sure I like Medtronic as a reseller because they will be pushing customers of the iport to their insulin pump….